OGI - OrganiGram Holdings Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.5400
-0.0500 (-3.14%)
At close: 4:00PM EDT

1.5700 +0.03 (1.95%)
After hours: 6:32PM EDT

Stock chart is not supported by your current browser
Previous Close1.5900
Open1.6300
Bid1.5300 x 21500
Ask1.5400 x 28000
Day's Range1.5300 - 1.6400
52 Week Range1.0900 - 7.0100
Volume2,619,000
Avg. Volume5,979,967
Market Cap301.323M
Beta (5Y Monthly)1.81
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Is Organigram Stock a Buy?
    Motley Fool

    Is Organigram Stock a Buy?

    Retail cannabis sales in Canada have rebounded from a brief dip in February, but Organigram (NASDAQ: OGI) stock hasn't followed. Organigram might look like a bargain at its depressed price, but there's a chance the company will disappoint investors again before the end of the month. Organigram recently postponed its fiscal third-quarter earnings report until Jul. 21, 2020, but still provided a disappointing snapshot of the top line figures.

  • OrganiGram Cutting Its Workforce by Roughly 25%
    Motley Fool

    OrganiGram Cutting Its Workforce by Roughly 25%

    Canadian marijuana grower and producer OrganiGram Holdings (NASDAQ: OGI) is downsizing. At the moment, 84 OrganiGram employees have been furloughed. Regarding the new reductions, OrganiGram wrote in the update that "[t]hese decisions are never easy to make, but we are committed to ensuring the Company is appropriately sized relative to market conditions."

  • Why OrganiGram Holdings Shares Are Sliding Today
    Motley Fool

    Why OrganiGram Holdings Shares Are Sliding Today

    Investors didn't like what they heard during the Canadian cannabis producer's announcement on Friday.

  • Can Cannabis 2.0 Products Boost Canopy Growth and Organigram in 2020?
    Motley Fool

    Can Cannabis 2.0 Products Boost Canopy Growth and Organigram in 2020?

    Will the potential of cannabis derivatives products push these two cannabis companies towards growth this year?

  • The Canadian Press

    Most actively traded companies on the TSX

    TORONTO — Some of the most active companies traded Friday on the Toronto Stock Exchange:Toronto Stock Exchange (15,596.75, down 25.65 points.)Harte Gold Corp. (TSX:HRT). Materials. Up three cents, or 23.08 per cent, to 16 cents on 4.7 million shares.The Bank of Nova Scotia (TSX:BNS). Financials. Up 54 cents, or 0.96 per cent, to $57 on 4.4 million shares.StageZero Life Sciences Ltd. (TSX:SZLS). Health care. Down half a cent, or 8.33 per cent, to 5.5 cents on 3.4 million shares.Moneta Porcupine Mines Inc. (TSX:ME). Materials. Down 2.5 cents, or 12.82 per cent, to 17 cents on 2.7 million shares.The Toronto-Dominion Bank (TSX:TD). Financials. Up five cents, or 0.08 per cent, to $60.65 on 2.5 million shares.Crescent Point Energy Corp. (TSX:CPG). Energy. Up six cents, or 2.69 per cent, to $2.29 on 2.2 million shares.Companies in the news:Organigram Holdings Inc. (TSX:OGI). Down 16 cents or 7.3 per cent to $2.03. Organigram Holdings Inc. is laying off at least 220 employees — and is warning more bad news could be on the way. The Moncton-based cannabis company said Friday the cuts will impact a quarter of its staff, but make the workforce leaner, more flexible and better prepared to align its production capacity with market conditions. The cuts will leave Organigram with a total workforce of 609 employees including 84 staff members who were previously temporarily laid off, but may be recalled if the company requires them. Organigram also said it will work to "right-size" production and review its assets. Both could cause Organigram to report a decline in net revenue in its forthcoming third quarter and incur writedowns on inventory and its Moncton facility, the company warned.Le Chateau Inc. (TSXV:CTU). Up 1.5 cents or 37.5 per cent to 5.5 cents. Le Chateau Inc. says it has started the manufacturing of up to 500,000 hospital gowns in partnership with Logistik Unicorp Inc. and its contract with the federal government. The retailer says all the gowns will be made in Canada. Le Chateau is a retailer and manufacturer of clothing, footwear and accessories for women and men. The company says it has historically manufactured about 30 per cent of its clothing in its own Canadian production facilities and is using them to produce the order. It is the latest Canadian firm to shift gears and start producing personal protective equipment for health care workers. Other clothing companies that have made the switch include Samuelsohn, Canada Goose and Arc'teryx.This report by The Canadian Press was first published July 3, 2020.The Canadian Press

  • Organigram lays off 220 workers, will cultivate less cannabis than expected
    The Canadian Press

    Organigram lays off 220 workers, will cultivate less cannabis than expected

    Organigram Holdings Inc. is laying off at least 220 employees — and is warning more bad news could be on the way.The Moncton-based cannabis company said Friday the cuts will impact a quarter of its staff, but make the workforce leaner, more flexible and better prepared to align its production capacity with market conditions."These decisions are never easy to make, but we are committed to ensuring the company is appropriately sized relative to market conditions," Organigram chief executive Greg Engel said in a statement.The cuts will leave Organigram with a total workforce of 609 employees including 84 staff members who were previously temporarily laid off, but may be recalled if the company requires them.Organigram also said it will work to "right-size" production and review its assets.Both could cause Organigram to report a decline in net revenue in its forthcoming third quarter and incur writedowns on inventory and its Moncton facility, the company warned.It also announced that for the foreseeable future Organigram will continue to cultivate less cannabis than its Moncton operation was designed to produce.The company will instead focus on using new strains of plants to meet emerging consumer demand.Organigram's cuts come as a handful of other Canadian cannabis companies including Aurora Cannabis Inc. and Canopy Growth Corp. have also turned to restructurings, writedowns and layoffs in an effort to keep their companies afloat.This report by The Canadian Press was first published July 3, 2020.Companies in this story: (TSX:OGI, TSX:ACB, TSX:WEED)Tara Deschamps, The Canadian Press

  • Organigram Provides Update on COVID-19 Corporate Action Plan and Timing for Q3 Results
    Business Wire

    Organigram Provides Update on COVID-19 Corporate Action Plan and Timing for Q3 Results

    Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI) (NASDAQ: OGI) provides a corporate update on recent developments of the Company in relation to the worldwide COVID-19 pandemic and the continuing evolution of the Canadian cannabis industry.

  • If You Had Invested $500 in OrganiGram Stock 5 Years Back, It Would Be Worth This Much Today!
    The Motley Fool

    If You Had Invested $500 in OrganiGram Stock 5 Years Back, It Would Be Worth This Much Today!

    OrganiGram has outperformed broader markets in the last five years. Can it continue to do so in the upcoming decade?The post If You Had Invested $500 in OrganiGram Stock 5 Years Back, It Would Be Worth This Much Today! appeared first on The Motley Fool Canada.

  • Ranking 3 Top Marijuana Stocks for 2020
    The Motley Fool

    Ranking 3 Top Marijuana Stocks for 2020

    Here's why cannabis investors should buy profitable stocks such as Aphria (TSX:APHA) and OrganiGram (TSX:OGI) right now. The post Ranking 3 Top Marijuana Stocks for 2020 appeared first on The Motley Fool Canada.

  • Organigram Holdings Inc. Provides Corporate Updates
    Business Wire

    Organigram Holdings Inc. Provides Corporate Updates

    Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announces a number of corporate updates.

  • Is OrganiGram (TSX:OGI) Stock a Buy Right Now?
    The Motley Fool

    Is OrganiGram (TSX:OGI) Stock a Buy Right Now?

    Here's why OgraniGram (TSX:OGI)(NASDAQ:OGI) stock might continue to underperform markets in 2020The post Is OrganiGram (TSX:OGI) Stock a Buy Right Now? appeared first on The Motley Fool Canada.

  • Why OrganiGram Holdings Stock Is Jumping Today
    Motley Fool

    Why OrganiGram Holdings Stock Is Jumping Today

    Shares of OrganiGram Holdings (NASDAQ: OGI) were 7.8% higher as of 11:44 a.m. EDT on Friday after rising as much as 11.5% earlier in the day. You can chalk the gain up to the overall stock market rebound after Thursday's big sell-off. There's one thing investors should do based on OrganiGram's move today: nothing.

  • OrganiGram to Supply Israeli Company With Up to 6 Metric Tons of Cannabis
    Motley Fool

    OrganiGram to Supply Israeli Company With Up to 6 Metric Tons of Cannabis

    The deal with medical marijuana company Canndoc could also help the OrganiGram reach other international markets.

  • Organigram and Canndoc Sign International Strategic Agreement
    Business Wire

    Organigram and Canndoc Sign International Strategic Agreement

    Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, today announced that it has entered into a multi-year agreement for supply of dried flower to one of Israel’s largest and most established medical cannabis producers, Canndoc Ltd. ("Canndoc"), a subsidiary of InterCure Ltd. (TASE: INCR/INCR.TA).

  • Better Cannabis Stock: OrganiGram or Aphria?
    Motley Fool

    Better Cannabis Stock: OrganiGram or Aphria?

    Aphria (NYSE: APHA) and OrganiGram (NASDAQ: OGI) are two Canadian cannabis producers that have struggled over the past year. OrganiGram's even done considerably worse than the Horizons Marijuana Life Sciences ETF (OTC: HMLSF), which is down 60% over the same period. Let's take a closer look at these two stocks to see whether the larger decline in price makes OrganiGram a better value buy, or if the divide between the two pot stocks will become even larger this year.

  • Do Options Traders Know Something About Organigram (OGI) Stock We Don't?
    Zacks

    Do Options Traders Know Something About Organigram (OGI) Stock We Don't?

    Investors need to pay close attention to Organigram (OGI) stock based on the movements in the options market lately.

  • Why Tilray and OrganiGram Holdings Got Slammed on Friday
    Motley Fool

    Why Tilray and OrganiGram Holdings Got Slammed on Friday

    A pair of marijuana stocks, Tilray (NASDAQ: TLRY) and OrganiGram Holdings (NASDAQ: OGI), both dropped notably in price on Friday (by 5.2% and 7%, respectively). The culprit seems to be another weed title, Canopy Growth (NYSE: CGC), which earlier in the day published an awful quarterly earnings release. Canopy Growth is a leading company in the sector.

  • Organigram Successfully Completes Amendment to Credit Facilities with Bank of Montreal
    Business Wire

    Organigram Successfully Completes Amendment to Credit Facilities with Bank of Montreal

    Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (collectively, the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that the Company has amended its credit agreement dated May 31, 2019, with Bank of Montreal ("BMO") as lead arranger and agent as well as a syndicate including three other lenders (the "Credit Agreement Amendment"). The Credit Agreement Amendment modifies certain terms of the $115 million term loan (the "Term Loan") and $25 million revolving credit facility (the "Revolver", and together with the Term Loan, the "Facilities").

  • Why Organigram Stock Surged Today
    Motley Fool

    Why Organigram Stock Surged Today

    Shares of Organigram Holdings (NASDAQ: OGI) were flying on Thursday after the company said it was rolling out its "cannabis 2.0" products to its medical marijuana customers. As of 3:27 p.m. EDT, Organigram's stock was up more than 12%. Cannabis 2.0 is a term used to describe second-generation marijuana products such as edibles and beverages, as opposed to cannabis 1.0 products like dried flower.

  • OrganiGram Releases Cannabis 2.0 Products To Medical Users
    Motley Fool

    OrganiGram Releases Cannabis 2.0 Products To Medical Users

    Vapes and chocolate edibles are among the new cannabis products the company is rolling out to medical marijuana consumers.

  • Organigram Rolls out Cannabis 2.0 Products to Medical Consumers
    Business Wire

    Organigram Rolls out Cannabis 2.0 Products to Medical Consumers

    Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that as of May 19th, 2020, the Company has extended its medical cannabis offering to include products from its cannabis 2.0 adult-use recreational portfolio.

  • Got $3,000? These 5 Beaten-Down Stocks Are Begging to Be Bought
    Motley Fool

    Got $3,000? These 5 Beaten-Down Stocks Are Begging to Be Bought

    No matter how dire things may have appeared in previous bear markets, bull-market rallies eventually erase all evidence of downward moves in the stock market. Also keep in mind that you don't have to be rich to generate a handsome return from the stock market. With the exception of the oil and gas industry, there's probably not a harder-hit industry lately than bank stocks.

  • Why Aurora Cannabis Stock Is Falling Today
    Motley Fool

    Why Aurora Cannabis Stock Is Falling Today

    Shares of Aurora Cannabis (NYSE: ACB) sank on Wednesday after analysts raised concerns that the popular marijuana stock's price gains may have come too far, too fast. As of 3 p.m. EDT, Aurora's stock was down more than 12%. Aurora's shares surged as much as 180% following the cannabis producer's better-than-expected third-quarter sales results on May 14.

  • 4 Signs the Cannabis Industry Is Still Ultra-High-Risk
    Motley Fool

    4 Signs the Cannabis Industry Is Still Ultra-High-Risk

    If you're looking to invest in the cannabis industry, you have to be prepared to take on some significant risks. The industry's been struggling during the past year, and a turnaround is not necessarily imminent. This year is already setting up to be a challenging one for many pot stocks, and investors should be careful not to be lured in by low prices.

  • Organigram (OGI) Catches Eye: Stock Jumps 11.7%
    Zacks

    Organigram (OGI) Catches Eye: Stock Jumps 11.7%

    Organigram (OGI) saw a big move last session, as its shares jumped nearly 12% on the day, amid huge volumes.